- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-0378
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
White paper on peanut allergy: treatment pathway ; volume:30 ; number:8 ; day:6 ; month:12 ; year:2021 ; pages:287-289 ; date:12.2021
Allergo journal international ; 30, Heft 8 (6.12.2021), 287-289, 12.2021
- Urheber
-
Klimek, Ludger
Lange, Lars
Blum, Lea Alexandra
Klimek, Felix
Nemat, Katja
Reese, Imke
Blumchen, Katharina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40629-021-00195-1
- URN
-
urn:nbn:de:101:1-2022021720101348273886
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klimek, Ludger
- Lange, Lars
- Blum, Lea Alexandra
- Klimek, Felix
- Nemat, Katja
- Reese, Imke
- Blumchen, Katharina
- SpringerLink (Online service)
Ähnliche Objekte (12)
White paper on peanut allergy: treatment pathway
White paper peanut allergy : Part 3: management and therapy of peanut allergy
White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics
White paper on peanut allergy – part 1: epidemiology, burden of disease, health economic aspects
Peanut Allergy: An Overview
Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
Adhesion molecules in experimental peanut allergy
Current developments in the treatment of peanut allergy
Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
Omalizumab as successful treatment option in severe peanut allergy
Importance of Ara h 6 in peanut allergy diagnosis
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
White paper on peanut allergy: treatment pathway
White paper peanut allergy : Part 3: management and therapy of peanut allergy
White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics
White paper on peanut allergy – part 1: epidemiology, burden of disease, health economic aspects
Peanut Allergy: An Overview
Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
Adhesion molecules in experimental peanut allergy
Current developments in the treatment of peanut allergy
Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
Omalizumab as successful treatment option in severe peanut allergy
Importance of Ara h 6 in peanut allergy diagnosis
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
White paper on peanut allergy: treatment pathway
White paper peanut allergy : Part 3: management and therapy of peanut allergy
White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics
White paper on peanut allergy – part 1: epidemiology, burden of disease, health economic aspects
Peanut Allergy: An Overview
Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
Adhesion molecules in experimental peanut allergy
Current developments in the treatment of peanut allergy
Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
Omalizumab as successful treatment option in severe peanut allergy
Importance of Ara h 6 in peanut allergy diagnosis